Clontab
Clontab
For treatment of irritable bowel syndrome

Indication

Clontab® are indicated for:

  • Functional Gastro-intestinal disorders.                     
  • Gastro-intestinal colics ( intestinal, colonic, biliary).
  • Irritable bowel syndrome.
  • Diverticular diseases.                                                      
  • Post-dysenteric colitis.                                                    
  • Control of gastro-intestinal manifestations, accompanying psychogenic and migrainous headache.             

Composition

Each film coated Tablet of Clontab® Contains:

  •    Sulpiride   25mg                                 
  •    Mebeverine  hydrochloride  100mg            

Dosage

  • One Tablet of Clontab® used as 3-4 times daily preferably 20 minutes before meals.

Clontab®  was carefully designed to achieve effective relief of gastrointestinal spasms and colics specially when presenting as psychosomatic manifestation of nervous tension ,mental stress, anxiety or other psychic states.

  • Clontab® contains sulpiride which is a selective central dopamine D2 receptor blocker .lt exerts a mood elevating effect due its neuroleptic effect and anti – emetic action.
  • Mebeverine is a potent direct antispasmodic acting mainly on the smooth muscles of the gastro- intestinal tract and  in particular more effective on the colonic spasm.
  • Mebeverine being not an anticholenergic compound does not produce any of the troublesome side effects of atropine or other anti-spasmodics with atropine like properties.

Clontab® is therefore ,an antispasmodic specially effective in functional gastro-intestinal disorders and is particularly safe in elderly group who might be suffering from prostatic enlargement, glaucoma, or cardiac problems.

Each film coated Tablet of Clontab® Contains:

  •    Sulpiride   25mg                                 
  •    Mebeverine  hydrochloride  100mg            

Clontab® are indicated for:

  • Functional Gastro-intestinal disorders.                     
  • Gastro-intestinal colics ( intestinal, colonic, biliary).
  • Irritable bowel syndrome.
  • Diverticular diseases.                                                      
  • Post-dysenteric colitis.                                                    
  • Control of gastro-intestinal manifestations, accompanying psychogenic and migrainous headache.             

Clontab® are contra-indicated in:

  • Patients with known hypersensitivity to any component of this drug.
  • Clontab® should not be administered during pregnancy and lactation unless strictly indicated.
  • In therapeutic doses Clontab®  is considered to possess negligible side effects.    
  • In higher doses, sleep disturbance may occur and occasionally galactorrhea  and menstrual disturbance may take place.
  • One Tablet of Clontab® used as 3-4 times daily preferably 20 minutes before meals.
  • Blister of 10 tablets, Pack of 2 blisters.
  • Hospital packs with different sizes.

Store in a dry place at a temperature below  30ºC .